282 related articles for article (PubMed ID: 10405519)
1. Specific cyclooxygenase-2 (COX-2) inhibitors.
Rubin BR
J Am Osteopath Assoc; 1999 Jun; 99(6):322-5. PubMed ID: 10405519
[TBL] [Abstract][Full Text] [Related]
2. Celecoxib: a COX-2 inhibitor.
Andrews SA; Wallace CK; Davis RL
Am J Manag Care; 1999 Apr; 5(4):511-8; quiz 522-4. PubMed ID: 10387389
[No Abstract] [Full Text] [Related]
3. Meloxicam: selective COX-2 inhibition in clinical practice.
Furst DE
Semin Arthritis Rheum; 1997 Jun; 26(6 Suppl 1):21-7. PubMed ID: 9219316
[TBL] [Abstract][Full Text] [Related]
4. COX-2 specific inhibitors offer improved advantages over traditional NSAIDs.
Urban MK
Orthopedics; 2000 Jul; 23(7 Suppl):S761-4. PubMed ID: 10914695
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of cyclooxygenase-2-specific inhibitors.
Cannon GW; Breedveld FC
Am J Med; 2001 Feb; 110 Suppl 3A():6S-12S. PubMed ID: 11173044
[TBL] [Abstract][Full Text] [Related]
6. Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: what can we expect?
Geis GS
Scand J Rheumatol Suppl; 1999; 109():31-7. PubMed ID: 10422544
[TBL] [Abstract][Full Text] [Related]
7. Celecoxib, a selective cyclooxygenase-2 inhibitor for the treatment of rheumatoid arthritis and osteoarthritis.
Goldenberg MM
Clin Ther; 1999 Sep; 21(9):1497-513; discussion 1427-8. PubMed ID: 10509845
[TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase-2: from arthritis treatment to new indications for the prevention and treatment of cancer.
Yamamoto DS; Viale PH
Clin J Oncol Nurs; 2003; 7(1):21-9. PubMed ID: 12629931
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-2 specificity and its clinical implications.
Lefkowith JB
Am J Med; 1999 May; 106(5B):43S-50S. PubMed ID: 10390127
[TBL] [Abstract][Full Text] [Related]
10. Selective cyclooxygenase-2 inhibitors.
Golden BD; Abramson SB
Rheum Dis Clin North Am; 1999 May; 25(2):359-78. PubMed ID: 10356423
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2 inhibition and side-effects of non-steroidal anti-inflammatory drugs in the gastrointestinal tract.
Meyer-Kirchrath J; Schrör K
Curr Med Chem; 2000 Nov; 7(11):1121-9. PubMed ID: 11032962
[TBL] [Abstract][Full Text] [Related]
12. COX-2: separating myth from reality.
McKenna F
Scand J Rheumatol Suppl; 1999; 109():19-29. PubMed ID: 10422543
[TBL] [Abstract][Full Text] [Related]
13. Basic therapy for rheumatoid arthritis: nonsteroidal anti-inflammatory drugs.
Daoud KF; Jackson CG; Williams HJ
Compr Ther; 1999; 25(8-10):427-33. PubMed ID: 10520445
[TBL] [Abstract][Full Text] [Related]
14. COX-1-sparing NSAIDs--is the enthusiasm justified?
Peterson WL; Cryer B
JAMA; 1999 Nov; 282(20):1961-3. PubMed ID: 10580464
[No Abstract] [Full Text] [Related]
15. The unmet anti-inflammatory needs in orthopedics.
Trippel SB
Am J Orthop (Belle Mead NJ); 1999 Mar; 28(3 Suppl):3-7. PubMed ID: 10193996
[TBL] [Abstract][Full Text] [Related]
16. A cross-sectional retrospective assessment of anti-arthritic drugs in patients with arthritis in Korea.
Lee MC; Lee S; Suh DC; Kim J; Kong SX;
Curr Med Res Opin; 2003; 19(7):597-602. PubMed ID: 14606981
[TBL] [Abstract][Full Text] [Related]
17. [Non-steroidal anti-inflammatory agents with selective inhibitory activity on cyclooxygenase-2. Interest and future prospects].
Blain H; Jouzeau JY; Netter P; Jeandel C
Rev Med Interne; 2000 Nov; 21(11):978-88. PubMed ID: 11109595
[TBL] [Abstract][Full Text] [Related]
18. COX-2 selective inhibitors in the treatment of arthritis: a rheumatologist perspective.
Hochberg MC
Curr Top Med Chem; 2005; 5(5):443-8. PubMed ID: 15974939
[TBL] [Abstract][Full Text] [Related]
19. New directions in symptomatic therapy for patients with osteoarthritis and rheumatoid arthritis.
Hochberg MC
Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):4-14. PubMed ID: 12528069
[TBL] [Abstract][Full Text] [Related]
20. COX-2 inhibitors.
Brooks PM; Day RO
Med J Aust; 2000 Oct; 173(8):433-6. PubMed ID: 11090038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
